Want to join the conversation?
$LLY, the maker of insulin Humalog, said that in 4Q15 it received approval for launching Portrazza, a lung cancer drug, in US. The company terminated basal insulin peglispro, a treatment for type 1 and type 2 diabetes. $LLY expanded its R&D facility in Indianapolis and announced the closure of animal health manufacturing facility in Sligo, Ireland.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.